Studies Reveal Rhabdomyosarcoma Patients Who Benefit From Radiotherapy
Researchers say they have identified which patients with rhabdomyosarcoma are most likely to benefit from radiotherapy.
Researchers say they have identified which patients with rhabdomyosarcoma are most likely to benefit from radiotherapy.
Atezolizumab produced sustained responses in more than a third of patients with alveolar soft part sarcoma in a phase 2 trial.
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
The Preserving Patient Access to Home Infusion Act could make home infusions more accessible, particularly for patients with cancer.
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.